Cellectis (CLLS) Earnings Analysis
Cellectis (CLLS) next reports earnings on 2026-08-11, consensus EPS -0.263 USD. Last quarter (2026-05-11) it beat with EPS -0.18 USD vs -0.25833 USD est (+30.3%). It has beaten estimates in 3/7 recent quarters (43%). Trailing P/E -4.23.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does CLLS next report earnings?
| Next earnings date | 2026-08-11 |
|---|---|
| Consensus EPS estimate | -0.263 USD |
| Revenue estimate | 0.01B |
CLLS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-11 | -0.18 USD | -0.25833 USD | +30.3% | Beat |
| 2026-03-19 | -0.26 USD | -0.20333 USD | -27.9% | Miss |
| 2025-11-07 | 0.01 USD | -0.1 USD | +110% | Beat |
| 2025-08-04 | -0.24 USD | -0.1 USD | -140% | Miss |
| 2025-05-12 | -0.18 USD | -0.19 USD | +5.3% | Beat |
| 2025-03-13 | -0.16 USD | 0.06 USD | -366.7% | Miss |
| 2024-11-04 | -0.23 USD | -0.2 USD | -15% | Miss |
Beat rate: 3/7 (43%) over reported quarters with consensus data.
CLLS valuation and analyst view
| Trailing P/E | -4.23 |
|---|---|
| Trailing EPS | -0.6683 USD |
| Price / book | 4.78 |
| Dividend yield | 0.00% |
| Market cap | 0.29B |
| Analyst consensus | Buy (14 buy / 2 hold / 1 sell) |
| Avg price target | 9 USD |
Related research pages
Frequently asked questions
When is Cellectis (CLLS)'s next earnings date?
Cellectis is next scheduled to report on 2026-08-11, with a consensus EPS estimate of -0.263 USD and revenue estimate of 0.01B.
Did CLLS beat earnings last quarter?
In its 2026-05-11 report, CLLS posted EPS of -0.18 USD versus a -0.25833 USD estimate — a beat of 30.3%.
What is CLLS's earnings track record?
Over the last 7 reported quarters with consensus data, CLLS beat estimates 3 times (43%).
What is CLLS's current P/E ratio and EPS?
CLLS trades at a trailing P/E of -4.23 on trailing EPS of -0.6683019840306824 USD.
What do analysts rate CLLS?
Analyst consensus is "Buy" across 17 ratings (0 strong buy, 14 buy, 2 hold, 1 sell, 0 strong sell). Average 12-month price target: 9 USD.